Ligand Pharmaceuticals Files 8-K
Ticker: LGNZZ · Form: 8-K · Filed: Jul 2, 2025 · CIK: 886163
| Field | Detail |
|---|---|
| Company | Ligand Pharmaceuticals Inc (LGNZZ) |
| Form Type | 8-K |
| Filed Date | Jul 2, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 8-K
Related Tickers: LGND
TL;DR
LGND filed a routine 8-K, no major news.
AI Summary
Ligand Pharmaceuticals Inc. filed an 8-K on July 2, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or material events beyond the standard reporting requirements for this date.
Why It Matters
This 8-K filing indicates Ligand Pharmaceuticals Inc. is meeting its regulatory reporting obligations with the SEC, which is standard practice for publicly traded companies.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for regulatory disclosure and does not contain any new material information that would indicate increased risk.
Key Players & Entities
- LIGAND PHARMACEUTICALS INC (company) — Registrant
- July 2, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 770160744 (identifier) — I.R.S. Employer Identification No.
- 555 Heritage Drive, Suite 200 Jupiter Florida 33458 (address) — Address of principal executive offices
- 858-550-7500 (phone_number) — Registrant's Telephone Number
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to file Financial Statements and Exhibits as of July 2, 2025.
What is the company's name and state of incorporation?
The company's name is Ligand Pharmaceuticals Inc., and it is incorporated in Delaware.
What is the address of Ligand Pharmaceuticals Inc.'s principal executive offices?
The address of Ligand Pharmaceuticals Inc.'s principal executive offices is 555 Heritage Drive, Suite 200 Jupiter Florida 33458.
What is the registrant's telephone number?
The registrant's telephone number is (858) 550-7500.
What is the filing date for this report?
The filing date for this report is July 2, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 2, 2025 regarding LIGAND PHARMACEUTICALS INC (LGNZZ).